Contents
Contents
Physician copay waiver fraud can involve using forgiven patient balances to induce government-paid business, inventing collection efforts, or billing Medicare for amounts the practice has waived. The telling detail may be an instruction to stop sending invoices, a hardship approval made without looking at the patient’s finances, or an account note describing a collection attempt nobody made. If you work in health care billing, patient accounts or practice management, you may know why the balance disappeared and who wanted it gone.
In physician billing fraud, a waived balance can leave a false account of the charge or collection effort behind it. Hudson Valley Hematology-Oncology Associates admitted billing Medicare for copays it had routinely waived. The whistleblower complaint against BioTek reMEDys, a pharmacy business working with referring physicians, described a different mechanism: employees allegedly created collection entries to justify writing balances off. One concerns what Medicare was billed. The other concerns a collection history allegedly invented inside the business.
Copays sit alongside deductibles and coinsurance in the patient’s cost-sharing obligations. A practice’s waiver policy, the decision on an individual account and the claim sent to the payer each answer a different question. We connect those records to understand what was forgiven, what was represented and which government program paid.
A hardship form can give a routine waiver the appearance of a review that never happened. A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published in the Journal of Forensic and Investigative Accounting in 2020, examines copayment waivers as inducements to use a provider. For a physician practice insider, that puts the focus on who approved the waiver and what information they considered.
In the BioTek complaint, former employees alleged that hardship forms went directly to the company’s commissioned chief marketing officer. According to their account, that officer approved waivers without discussing the patient’s circumstances or analyzing the patient’s finances. They also alleged that assistance was approved for a patient the officer did not know because a referring physician would sign the paperwork.
We see the absurdity in that alleged arrangement: financial hardship, approved by the sales side. The commissioned marketing officer decided who received assistance, and the referring physician could supply the signature. The label on the form did less to explain the decision than the people directing it.
The BioTek whistleblowers’ complaint alleged that employees manufactured evidence of collection attempts before writing off unpaid balances. The employees described the work inside CPR+, the account system, in unusually concrete terms:
In many instances, Biotek employees were instructed to falsely make entries next to each unpaid balance in CPR+ to make it appear as though the Pharmacies attempted three collection efforts before writing off the balance. In reality, no collection efforts were made.
United States ex rel. Wyatt v. BioTek reMEDys, Inc., whistleblowers’ complaint, paragraph 73
The alleged entries supplied the appearance of a reason to abandon collection. A billing employee could see the unpaid balance, the instruction to create the notes and the write-off that followed. We would compare the entries with the work the employee actually performed and the instructions that produced them.
The complaint also alleged that executives dismissed an insider’s concerns and repeated the instruction not to invoice patients for balances owed. That connects an account-level practice to a management decision. The person entering the adjustment may know both what the system was made to show and who insisted on it.
The same complaint alleged that BioTek designated its foundation as the responsible payer for patient cost sharing. It then described what happened to the money:
By indicating in the CPR+ system that the patient qualified for financial hardship assistance through the Biotek Foundation, the Biotek Foundation was designated as the responsible payer for the patient cost-sharing balance. Ultimately, the cost-sharing balance was written off without any funds ever being applied to the account.
United States ex rel. Wyatt v. BioTek reMEDys, Inc., whistleblowers’ complaint, paragraph 79
A new payer name supplied the explanation for where the balance went. According to the complaint, no payment followed that designation. We would trace the foundation entry through to the adjustment and the money received, because those records answer whether the account was funded or simply cleared.
A patient-facing waiver can support the same referral arrangement as benefits given to the physician. BioTek’s complaint alleged that special CPR+ alerts flagged patients referred by selected physicians and reminded employees not to invoice those patients for cost sharing. The alleged collection decision followed the referral source.
The complaint separately alleged expensive meals, entertainment and free administrative, clinical and insurance support for referring physicians and their practices. Together, those allegations connect physician kickbacks to the patient account: the physician received benefits while selected patients avoided invoices. Someone managing referrals could recognize the relationship that a billing employee saw only as an alert.
Busting Bad Medicine: a Call to Action Addressing Healthcare, Fraud, Waste, and Abuse, published in the Journal of AHIMA in 2017, explains how kickbacks can distort medical decisions, steer patients and disadvantage competitors. Physicians direct patients toward drugs, specialists and suppliers, which makes their referral decisions commercially valuable. The BioTek allegations show how the patient balance can become part of that sales effort.
In its October 2023 settlement announcement, the Justice Department said BioTek and its chief executive agreed to pay $20 million to resolve allegations involving routine copayment waivers and physician referral benefits. A referring neurologist separately paid $480,000. The whistleblowers had alleged $1.8 million in waived cost-sharing balances in 2018 alone, a large percentage for Medicare beneficiaries.
Hudson Valley Hematology-Oncology Associates admitted routinely waiving copays without individualized, documented hardship findings or exhausted reasonable collection efforts. It then billed Medicare for those waived amounts. The practice forgave the patient’s obligation and sought payment from the government anyway.
The Justice Department announced a $5.31 million civil settlement in October 2016. The settlement also covered other billing allegations.
For an employee, the useful comparison is between the waiver decision and the Medicare bill. A patient account may show that a balance was forgiven while the claim history shows the practice sought payment for it anyway. Hudson Valley gives that comparison an admitted example, alongside BioTek’s allegations about invented collections and referral-linked waivers.
The whistleblowers in the Tareen Dermatology complaint alleged that patients were asked to sign hardship forms regardless of their actual financial condition, to induce them to accept repeat services. The alleged purpose of the form was to secure repeat visits. Someone watching those forms move through the office could connect the waiver policy to the additional services being offered.
Tareen Dermatology and its physician and chief executive agreed to pay $1,630,000 in June 2024 to resolve allegations involving Medicare and programs administered by the Department of Veterans Affairs. The copay waivers sat alongside other billing allegations. The case puts the hardship form beside the services and claims it allegedly helped generate.
The CityMD whistleblower complaint described a patient asking about a copay and an administrator responding that the patient would owe none and that she would delete the insurance information. The patient alleged that a later portal review showed the insurance details replaced with “Uninsured Insurance.”
The Justice Department’s 2024 CityMD settlement announcement concerned allegations of claims to the federal COVID-19 Uninsured Program for insured patients. In the alleged scheme, the representation changed at registration and reached a government payment program. The connection a whistleblower could see was between the insurance information provided, the change in the record and the resulting claim.
The evidence runs from the patient’s obligation through the waiver decision to the payer’s claim. We connect the hardship approvals, collection notes, balance adjustments and referral instructions with you to understand how the account changed and which government claims followed.
Payer identity belongs in that comparison. Medicare Advantage and Medicaid managed-care plans contract with practices, so private administration can sit between the practice and government money. We examine the payer terms and the actual claims with you to establish where that money came from.
A physician practice qui tam case can bring an insider’s account of those decisions to bear on false government claims. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Your knowledge of why the account changed gives us a place to begin.
If you saw hardship approvals without review, collection notes invented or referral instructions controlling who received a bill, speak with our whistleblower experts about what happened inside the practice. We work beside you to build the case around those decisions and the government claims they produced, and bring in healthcare fraud whistleblower lawyers who understand patient billing and referral arrangements. From the first conversation through the case, we are your partners in making that knowledge count.